8-18060379-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_177924.5(ASAH1):​c.786-676G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 152,348 control chromosomes in the GnomAD database, including 12,954 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12919 hom., cov: 32)
Exomes 𝑓: 0.38 ( 35 hom. )

Consequence

ASAH1
NM_177924.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.430

Publications

12 publications found
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
  • ASAH1-related sphingolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Farber lipogranulomatosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • spinal muscular atrophy-progressive myoclonic epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.64 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASAH1NM_177924.5 linkc.786-676G>A intron_variant Intron 10 of 13 ENST00000637790.2 NP_808592.2 Q13510-1Q53H01A8K0B6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASAH1ENST00000637790.2 linkc.786-676G>A intron_variant Intron 10 of 13 1 NM_177924.5 ENSP00000490272.1 Q13510-1

Frequencies

GnomAD3 genomes
AF:
0.401
AC:
60892
AN:
151838
Hom.:
12903
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.374
Gnomad AMI
AF:
0.404
Gnomad AMR
AF:
0.551
Gnomad ASJ
AF:
0.516
Gnomad EAS
AF:
0.654
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.355
Gnomad OTH
AF:
0.409
GnomAD4 exome
AF:
0.375
AC:
147
AN:
392
Hom.:
35
Cov.:
0
AF XY:
0.369
AC XY:
87
AN XY:
236
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AF:
0.800
AC:
16
AN:
20
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
2
AN:
4
East Asian (EAS)
AF:
0.667
AC:
8
AN:
12
South Asian (SAS)
AF:
0.500
AC:
3
AN:
6
European-Finnish (FIN)
AF:
0.250
AC:
1
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.331
AC:
110
AN:
332
Other (OTH)
AF:
0.583
AC:
7
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.401
AC:
60958
AN:
151956
Hom.:
12919
Cov.:
32
AF XY:
0.409
AC XY:
30374
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.374
AC:
15497
AN:
41434
American (AMR)
AF:
0.552
AC:
8432
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.516
AC:
1790
AN:
3470
East Asian (EAS)
AF:
0.654
AC:
3356
AN:
5128
South Asian (SAS)
AF:
0.659
AC:
3170
AN:
4808
European-Finnish (FIN)
AF:
0.306
AC:
3232
AN:
10568
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.355
AC:
24159
AN:
67964
Other (OTH)
AF:
0.406
AC:
853
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1767
3535
5302
7070
8837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.374
Hom.:
20796
Bravo
AF:
0.414
Asia WGS
AF:
0.609
AC:
2118
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.81
DANN
Benign
0.44
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10112857; hg19: chr8-17917888; API